Application of intrahepatic fiducial markers in carbon ion radiotherapy for pancreatic cancer—Achieving higher precision treatment
The proposed MM approach corrected interfractional target motion, achieving target coverage comparable to TM. In pancreatic cancer CIRT, managing gastrointestinal gas and body contour changes along with tumor motion may further optimize target coverage and improve clinical outcomes.
Authors
- Yoshiki Takayama
- Tadashi Kamada (ORCID: https://orcid.org/0000-0002-9848-7368)
- Masataka Komori (ORCID: https://orcid.org/0000-0002-4545-4917)
- Junya Nagata (ORCID: https://orcid.org/0000-0001-8735-1839)
- Yohsuke Kusano (ORCID: https://orcid.org/0000-0002-4792-2016)
- Shohei Kawashiro (ORCID: https://orcid.org/0000-0001-5524-3948)
- Shogo Kurokawa
- Hiroyuki Katoh (ORCID: https://orcid.org/0000-0002-0804-7271)
- Atsushi Ito (ORCID: https://orcid.org/0009-0000-6344-1581)
- Daisaku Yoshida
Institutions
- Kanagawa Prefectural Hospital Organization (JP)
- Nagoya City University (JP)
- Nagoya Medical Center (JP)
- Kanagawa Cancer Center
- Nagoya University (JP)
Publication Details
- Journal
- Journal of Applied Clinical Medical Physics
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1002/acm2.70427
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00